Skip to main content
. 2019 Nov 25;17(11):1115–1128. doi: 10.1111/ddg.13973

Table 3.

Diseases causing livedo racemosa

Affected vessels: capillaries (c), postcapillary venules (pv), arterioles/arteries (a), veins (v)
Vasculitic
  • Polyarteritis nodosa (a)

  • Nodular vasculitis (erythema induratum) (a)

  • Granulomatosis with polyangiitis (Wegener's granulomatosis) (pv = a)

  • Eosinophilic granulomatosis with polyangiitis (Churg‐Strauss syndrome) (pv = a)

  • Microscopic polyangiitis (pv = a)

  • Takayasu's arteritis (in rare cases of acute occlusion of the affected vessel) (a)

  • Sepsis (disseminated intravascular coagulation) (c > pv)

Non‐vasculitic
  • Sneddon syndrome (a)

  • Systemic lupus erythematosus (c = pv = a)

  • Anti‐phospholipid syndrome (Hughes syndrome) (c = pv = a)

  • Calciphylaxis (a)

  • Cholesterol embolus (a)

  • Arteriosclerosis/arteriolosclerosis (a)

  • Stroke (via neurohumoral pathways) (a)

  • Coagulopathies as protein S & C, AT‐III or tPA deficiency (pv = a)

  • Livedovasculopathy (c > pv)

  • Thrombocythemia, polycythemia vera, sickle cell anemia, thalassemia (c > pv)

  • Cryoglobulins (c > pv)

  • Cold agglutinins (c > pv)

  • Levamisole (cocaine adulterant) 14 (c > pv)

  • Neurofibromatosis (a)

  • Fibromuscular dysplasia (a)

  • Cutis marmorata telangiectatica congenita (congenital livedo, van Lohuizen syndrome; usually causes livedo reticularis) (c < pv)